JPRN-UMIN000007102已完成2 期
A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung cancer - A phase II study of carboplatin and amurubicin with a biweekly schedule in patients with advanced squamous cell lung cancer
ational Hospital Organization Kyushu Medical Center Department of Respiratory Medicine0 个研究点目标入组 25 人开始时间: 2012年1月19日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Serious infections 2)Serious clinical problems 3)Interstitial pneumonia/lung fibrosis on chest CT 4)Active concomitant malignancy 5)Symptomatic brain metastasis 6)Massive pericardial, pleural effusion, ascites 7)Previous drug allergy 8)Those judged to be not suitable by the attending physician
研究者
相似试验
未知
2 期
Phase II study in combination with Carboplatin and TS-1 for Cancer of unknown primaryCancer of unknown primaryJPRN-UMIN000001236ational Cancer Center Hospital, Tokyo35
已完成
不适用
Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinomaThymoma/Thymic carcinomaJPRN-UMIN000002619Tohoku University Hospital40
已完成
不适用
Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancerJPRN-UMIN000002618Tohoku University Hospital30
招募中
1 期
Phase I study of Amrubicin plus CISplatin and concurrent accelerated hyperfractionated thoracic radioTherapy for limited-disease small cell lung cancerJPRN-jRCT1071200033Taniguchi Hirokazu9
进行中（未招募）
2 期
A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine CarcinomasACTRN12616000958482Australasian Gastro-Intestinal Trials Group (AGITG)60